Predicta Biosciences
$24.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Predicta Biosciences is currently valued at $49.0M as of October 1, 2025. The company has raised a total of $29.2M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.68x, Predicta Biosciences has achieved a valuation that is 1.68 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Predicta Biosciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Predicta Biosciences Worth in 2025?
As of 2025, Predicta Biosciences is valued at $49.0M, based on the company's Early Stage VC funding round in October 1, 2025. This valuation positions Predicta Biosciences as one of the leading private companies in the sector.
Predicta Biosciences Valuation History
Predicta Biosciences's funding history demonstrates steady growth and investor confidence.
How Predicta Biosciences Valuation is Determined
Private company valuations like Predicta Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Predicta Biosciences Valuation FAQs
Is Predicta Biosciences profitable?
Predicta Biosciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Predicta Biosciences's valuation compare to competitors?
Predicta Biosciences is valued at $49.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Predicta Biosciences IPO?
Predicta Biosciences has not announced plans for an initial public offering. Until an IPO, investors can access Predicta Biosciences shares through secondary market platforms.